Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis
Status unconfirmed · Phase 2 · Has a placebo group
Conditions studied: Decompensated Cirrhosis
In brief
This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of emricasan in improving event-free survival based on a composite clinical endpoint (where all-cause mortality, new decompensation events, and MELD score progression are events) in subjects with decompensated NASH cirrhosis.
Key facts
- Study ID
- NCT03205345
- Run by
- Conatus Pharmaceuticals Inc.
- People needed
- 210
- Starts
- 2017-06-28
- Expected to finish
- 2019-08-01
- Last updated by the study team
- 2019-03-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital & Medical Center — Phoenix, Arizona, United States
- Mayo Clinic Arizona — Phoenix, Arizona, United States
- University of Arizona Liver Research Institute — Tucson, Arizona, United States
- University of California, San Francisco-Fresno — Fresno, California, United States
- Cedars Sinai Medical Center — Los Angeles, California, United States
- UCLA Pfleger Liver Institute — Los Angeles, California, United States
- California Liver Research Institute — Pasadena, California, United States
- Stanford University — Redwood City, California, United States
- Inland Empire Liver Foundation — Rialto, California, United States
- UC Davis GI/Hepatology Clinical Trials Unit — Sacramento, California, United States
- Scripps Clinic - Torrey Pines — San Diego, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of California San Francisco — San Francisco, California, United States
- University of Colorado Denver — Aurora, Colorado, United States
- Peak Enterology Associates — Colorado Springs, Colorado, United States
- West Haven VA Medical Center — West Haven, Connecticut, United States
- UF Hepatology Research at CTRB — Gainesville, Florida, United States
- Mayo Clinic — Jacksonville, Florida, United States
- Florida Research Institute — Lakewood Rch, Florida, United States
- Schiff Center for Liver Disease/University of Miami — Miami, Florida, United States
- Florida Hospital Transplant Institute — Orlando, Florida, United States
- IMIC Inc. — Palmetto Bay, Florida, United States
- Tampa General Hospital — Tampa, Florida, United States
- Piedmont Transplant Institute — Atlanta, Georgia, United States
- The Institute for Liver Health — Chandler, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.